Common phenotypic expression of gangliosides GM3 and GD3 in normal human tissues and neoplastic skin lesions.
The expression of gangliosides in non-malignant tissues (epidermis and pigmented nevus) and neoplastic lesions (melanoma, squamous cell carcinoma [SCC] and basal cell carcinoma [BCS]) of the human skin was analyzed immunohistochemically and biochemically to characterize the features associated with malignancy. Immunohistochemical staining with an anti-II3NeuAc-LacCer (GM3) monoclonal antibody (M2590 mAb) and an anti-II3(NeuAc)2-LacCer (GD3) mAb (R24) showed the expression of the gangliosides GM3 and GD3 to vary among the different tissues. M2590 clearly stained epidermal keratinocytes and the tumor cells of BCC and SCC, and strongly stained melanocytes and melanoma cells. In contrast, R24 did not stain epidermal keratinocytes and only faintly stained SCC cells, while it clearly stained BCC cells, and intensely stained melanocytes and melanoma cells. GM3 showed a similar level of staining among the tissue specimens, while the level of GD3 staining was quite variable among the tumor specimens. Biochemical analysis by thin-layer chromatography (TLC) with resorcinol staining and TLC immunostaining with either M2590 or R24 showed both GM3 and GD3 to be commonly expressed by both the normal and malignant skin tissues, including SCC. There was no close correlation between the intensity of immunohistochemical staining and the biochemically detected amounts of these gangliosides. This may have been partly due to the so-called cryptic expression of cell membrane gangliosides. Our results thus suggest that analysis of the tumor-associated expression of gangliosides requires several methods, since the sensitivity of the methods used may have a considerable effect on the diagnostic value of gangliosides as skin cancer markers.
Nakakuma
H
H
Second Department of Internal Medicine, Kumamoto University Medical School.
Horikawa
K
K
Kawaguchi
T
T
Hidaka
M
M
Nagakura
S
S
Hirai
S
S
Kageshita
T
T
Ono
T
T
Kagimoto
T
T
Iwamori
M
M
D014408:Biomarkers, Tumor / Q000032:analysis; D002280:Basal Cell Carcinoma / Q000737:chemistry / Q000473:pathology; D002294:Carcinoma, Squamous Cell / Q000737:chemistry / Q000473:pathology; D003713:Dendritic Cells / Q000737:chemistry / Q000473:pathology; D004817:Epidermis / Q000737:chemistry / Q000473:pathology; D005679:G(M3) Ganglioside / Q000032:analysis* / Q000235:genetics; D005732:Gangliosides / Q000032:analysis* / Q000235:genetics; D015870:Gene Expression; D006801:Humans; D007124:Immunoenzyme Techniques; D008544:Melanocytes / Q000737:chemistry / Q000473:pathology; D008545:Melanoma / Q000737:chemistry / Q000473:pathology; D009508:Nevus, Pigmented / Q000737:chemistry / Q000473:pathology; D010641:Phenotype; D012867:Skin / Q000737:chemistry* / Q000473:pathology; D012878:Skin Neoplasms / Q000737:chemistry* / Q000473:pathology
D014408:Biomarkers, Tumor; D005679:G(M3) Ganglioside; D005732:Gangliosides; C026226:ganglioside, GD3